Becton Dickinson Operating Expenses 2010-2024 | BDX

Becton Dickinson annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Becton Dickinson operating expenses for the quarter ending September 30, 2024 were $4.787B, a 1.08% increase year-over-year.
  • Becton Dickinson operating expenses for the twelve months ending September 30, 2024 were $17.754B, a 2.86% increase year-over-year.
  • Becton Dickinson annual operating expenses for 2024 were $17.752B, a 2.84% increase from 2023.
  • Becton Dickinson annual operating expenses for 2023 were $17.261B, a 4.06% increase from 2022.
  • Becton Dickinson annual operating expenses for 2022 were $16.587B, a 1.74% decline from 2021.
Becton Dickinson Annual Operating Expenses
(Millions of US $)
2024 $17,752
2023 $17,261
2022 $16,587
2021 $16,880
2020 $15,162
2019 $15,530
2018 $14,474
2017 $10,571
2016 $11,053
2015 $9,208
2014 $6,840
2013 $6,799
2012 $6,150
2011 $5,919
2010 $5,542
2009 $5,397
Becton Dickinson Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $4,787
2024-06-30 $4,388
2024-03-31 $4,311
2023-12-31 $4,268
2023-09-30 $4,736
2023-06-30 $4,331
2023-03-31 $4,194
2022-12-31 $4,000
2022-09-30 $4,272
2022-06-30 $4,104
2022-03-31 $4,184
2021-12-31 $4,027
2021-09-30 $4,218
2021-06-30 $4,115
2021-03-31 $4,474
2020-12-31 $4,073
2020-09-30 $4,058
2020-06-30 $3,496
2020-03-31 $3,884
2019-12-31 $3,724
2019-09-30 $4,473
2019-06-30 $3,724
2019-03-31 $4,059
2018-12-31 $3,274
2018-09-30 $3,827
2018-06-30 $3,767
2018-03-31 $4,035
2017-12-31 $2,845
2017-09-30 $2,676
2017-06-30 $3,259
2017-03-31 $2,524
2016-12-31 $2,112
2016-09-30 $3,135
2016-06-30 $2,682
2016-03-31 $2,602
2015-12-31 $2,634
2015-09-30 $2,765
2015-06-30 $2,983
2015-03-31 $1,758
2014-12-31 $1,702
2014-09-30 $1,801
2014-06-30 $1,711
2014-03-31 $1,691
2013-12-31 $1,637
2013-09-30 $2,024
2013-06-30 $1,648
2013-03-31 $1,619
2012-12-31 $1,508
2012-09-30 $1,578
2012-06-30 $1,532
2012-03-31 $1,546
2011-12-31 $1,495
2011-09-30 $1,504
2011-06-30 $1,505
2011-03-31 $1,482
2010-12-31 $1,429
2010-09-30 $1,309
2010-06-30 $1,408
2010-03-31 $1,386
2009-12-31 $1,439
2009-09-30 $1,345
2009-06-30 $1,388
2009-03-31 $1,364
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.746B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36